JENNIFER PATE: Open Payments
NPI 1972048304 · FLOWOOD, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$418 in 25 payments from 9 companies in 2025. Trend: 2023 $905 · 2024 $1,312 · 2025 $418
Food & beverage: $418
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 11 | $150 |
| PFIZER INC. | 4 | $81 |
| Pulmonx Corporation | 4 | $72 |
| La Jolla Pharmaceutical Company | 1 | $22 |
| Verona Pharma, Inc. | 1 | $21 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $20 |
| GENZYME CORPORATION | 1 | $18 |
| Novocure Inc. | 1 | $18 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $16 |
Products named: TRELEGY ELLIPTA, CHARTIS CATHETER, ELIQUIS, GIAPREZA, Ohtuvayre, NUCALA, AREXVY, DUPIXENT.
Industry payments across MS — which companies pay providers there.
